MB-dNPM1-TCR.1
/ Miltenyi Biomedicine
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 16, 2024
MB-dNPM1-TCR.1 in Relapsed/Refractory AML
(clinicaltrials.gov)
- P1/2 | N=29 | Recruiting | Sponsor: Miltenyi Biomedicine GmbH | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
May 22, 2024
MB-dNPM1-TCR.1 in Relapsed/Refractory AML
(clinicaltrials.gov)
- P1/2 | N=29 | Not yet recruiting | Sponsor: Miltenyi Biomedicine GmbH
New P1/2 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
1 to 2
Of
2
Go to page
1